Welcome to LookChem.com Sign In|Join Free

CAS

  • or

334477-30-4

Post Buying Request

334477-30-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

334477-30-4 Usage

Type of compound

Cyclopropane derivative

Functional group

Trifluoromethylphenyl

Application

Organic synthesis and pharmaceutical research

Use

Building block in the production of pharmaceutical drugs and agrochemicals

Trifluoromethyl group

Contributes to high lipophilicity and stability

Importance

Key component in the development of bioactive compounds and drug candidates

Check Digit Verification of cas no

The CAS Registry Mumber 334477-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,4,4,7 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 334477-30:
(8*3)+(7*3)+(6*4)+(5*4)+(4*7)+(3*7)+(2*3)+(1*0)=144
144 % 10 = 4
So 334477-30-4 is a valid CAS Registry Number.

334477-30-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[3,5-bis(trifluoromethyl)phenyl]cyclopropanecarboxylic acid

1.2 Other means of identification

Product number -
Other names 1-(3,5-bis(trifluoromethyl)phenyl)cyclopropane-1-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:334477-30-4 SDS

334477-30-4Relevant articles and documents

Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK1 receptor antagonists

Sabbatini, Fabio M.,Fabio, Romano Di,Griffante, Cristiana,Pentassuglia, Giorgio,Zonzini, Laura,Melotto, Sergio,Alvaro, Giuseppe,Capelli, Anna M.,Pippo, Lara,Perdona', Elisabetta,Denis, Yves St.,Costa, Silvano,Corsi, Mauro

scheme or table, p. 623 - 627 (2010/06/12)

A focused exploration targeting conformationally restricted analogues of Vestipitant, resulted in the discovery of novel, in vitro potent NK1 antagonists. In particular, two of the compounds reported exhibited a good pharmacokinetic (PK) profile and produced anxiolytic-like effects in the gerbil foot tapping (GFT) in vivo model.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 334477-30-4